JY
TLSIW icon

Jeff Yass’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Jeff Yass’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,661
Closed -$1K – 13669
2022
Q3 		$1K Sell
20,661
-2,707
-12% -$194 ﹤0.01% 12991
2022
Q2 		$2K Buy
+23,368
New +$4.47K ﹤0.01% 12691

Other funds holding TLSIW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jeff Yass's TLSIW Position: Q4 2022 in Review

Jeff Yass sold out of TriSalus Life Sciences Warrant (TLSIW) in Q4 2022, closing a stake of 20,661 shares — an estimated $1K sold.

Jeff Yass first reported a position in TLSIW in Q2 2022 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 29 funds tracked by Wall St. Rank hold TLSIW as of Q4 2022.

  • Jeff Yass reported no remaining TriSalus Life Sciences Warrant position as of Q4 2022 after selling out during the quarter.
  • Jeff Yass sold 20,661 TriSalus Life Sciences Warrant shares in Q4 2022, an estimated $1K.
  • Jeff Yass first reported a position in TriSalus Life Sciences Warrant in Q2 2022 and held it in 2 quarters.
  • Jeff Yass's TriSalus Life Sciences Warrant position peaked at $2K in Q2 2022.
  • 29 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.